1. Home
  2. BDSX vs PCYO Comparison

BDSX vs PCYO Comparison

Compare BDSX & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • PCYO
  • Stock Information
  • Founded
  • BDSX 2005
  • PCYO 1976
  • Country
  • BDSX United States
  • PCYO United States
  • Employees
  • BDSX N/A
  • PCYO N/A
  • Industry
  • BDSX Precision Instruments
  • PCYO Water Supply
  • Sector
  • BDSX Health Care
  • PCYO Utilities
  • Exchange
  • BDSX Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • BDSX 115.4M
  • PCYO 248.0M
  • IPO Year
  • BDSX 2020
  • PCYO N/A
  • Fundamental
  • Price
  • BDSX $0.28
  • PCYO $11.09
  • Analyst Decision
  • BDSX Strong Buy
  • PCYO
  • Analyst Count
  • BDSX 5
  • PCYO 0
  • Target Price
  • BDSX $1.75
  • PCYO N/A
  • AVG Volume (30 Days)
  • BDSX 1.8M
  • PCYO 40.5K
  • Earning Date
  • BDSX 08-06-2025
  • PCYO 07-09-2025
  • Dividend Yield
  • BDSX N/A
  • PCYO N/A
  • EPS Growth
  • BDSX N/A
  • PCYO 118.08
  • EPS
  • BDSX N/A
  • PCYO 0.59
  • Revenue
  • BDSX $74,463,000.00
  • PCYO $29,911,000.00
  • Revenue This Year
  • BDSX $17.29
  • PCYO N/A
  • Revenue Next Year
  • BDSX $29.33
  • PCYO N/A
  • P/E Ratio
  • BDSX N/A
  • PCYO $18.84
  • Revenue Growth
  • BDSX 35.76
  • PCYO 58.85
  • 52 Week Low
  • BDSX $0.17
  • PCYO $9.10
  • 52 Week High
  • BDSX $2.04
  • PCYO $14.63
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 42.55
  • PCYO 63.99
  • Support Level
  • BDSX $0.25
  • PCYO $10.16
  • Resistance Level
  • BDSX $0.31
  • PCYO $11.16
  • Average True Range (ATR)
  • BDSX 0.02
  • PCYO 0.33
  • MACD
  • BDSX 0.01
  • PCYO 0.09
  • Stochastic Oscillator
  • BDSX 40.00
  • PCYO 93.97

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: